• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 miRNA 表达谱数据的荟萃分析并未揭示 B 细胞急性淋巴细胞白血病的共识特征。

Meta-analysis of microRNA profiling data does not reveal a consensus signature for B cell acute lymphoblastic leukemia.

机构信息

Department of Biochemistry, Memorial University of Newfoundland, St. John's, NL, Canada.

Department of Biochemistry, Memorial University of Newfoundland, St. John's, NL, Canada.

出版信息

Gene. 2022 May 5;821:146211. doi: 10.1016/j.gene.2022.146211. Epub 2022 Feb 5.

DOI:10.1016/j.gene.2022.146211
PMID:35134470
Abstract

B cell acute lymphoblastic leukemia (B-ALL) is the most prevalent pediatric cancer. MicroRNAs (miRNAs) are 18-22nt non-coding transcripts shown to be essential for the development of many cancers. While some miRNAs are reportedly expressed differentially between healthy and B-ALL, no studies have reported a consensus miRNA signature. Therefore, we performed a reanalysis of five miRNA datasets to identify differentially expressed miRNAs (DEmiRs) and a meta-analysis of previously identified DEmiRs from 25 studies. Overall, the re-analysis showed that the DEmiR data clustered by platform and not by disease state. The meta-analysis also did not reveal a consensus miRNA signature as there were many miRNAs upregulated in some studies and downregulated in others. However, eight promising miRNAs (miR-181b, miR-128b, miR-181a, miR-128, miR-128a, miR-181c, miR-155, miR-142-3p, and miR-451) were identified from the meta-analysis, which could be the basis of future investigations. These analyses reveal that standardization of miRNA isolation and analysis is needed in B-ALL to enable cross-study comparisons and identify a consensus signature.

摘要

B 细胞急性淋巴细胞白血病 (B-ALL) 是最常见的儿科癌症。microRNAs (miRNAs) 是 18-22nt 的非编码转录物,被证明对许多癌症的发展至关重要。虽然有报道称一些 miRNAs 在健康人和 B-ALL 之间表达差异,但没有研究报道一致的 miRNA 特征。因此,我们对五个 miRNA 数据集进行了重新分析,以确定差异表达的 miRNAs (DEmiRs),并对 25 项研究中之前确定的 DEmiRs 进行了荟萃分析。总体而言,重新分析表明,DEmiR 数据按平台而不是疾病状态聚类。荟萃分析也没有揭示出一致的 miRNA 特征,因为在一些研究中上调,而在另一些研究中下调。然而,从荟萃分析中确定了八个有前途的 miRNAs(miR-181b、miR-128b、miR-181a、miR-128、miR-128a、miR-181c、miR-155、miR-142-3p 和 miR-451),它们可能是未来研究的基础。这些分析表明,B-ALL 中需要 miRNA 分离和分析的标准化,以实现跨研究比较和确定一致的特征。

相似文献

1
Meta-analysis of microRNA profiling data does not reveal a consensus signature for B cell acute lymphoblastic leukemia.基于 miRNA 表达谱数据的荟萃分析并未揭示 B 细胞急性淋巴细胞白血病的共识特征。
Gene. 2022 May 5;821:146211. doi: 10.1016/j.gene.2022.146211. Epub 2022 Feb 5.
2
[Bioinformatics analysis of microRNA comprehensive regulatory network in B- cell acute lymphoblastic leukemia].B细胞急性淋巴细胞白血病中微小RNA综合调控网络的生物信息学分析
Zhonghua Xue Ye Xue Za Zhi. 2016 Jul;37(7):585-90. doi: 10.3760/cma.j.issn.0253-2727.2016.07.009.
3
MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.微小 RNA 表达谱可区分儿童 T 细胞和 B 细胞急性淋巴细胞白血病。
Hematol Oncol. 2019 Feb;37(1):103-112. doi: 10.1002/hon.2567. Epub 2018 Nov 27.
4
Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.全基因组鉴定与费城染色体阳性急性淋巴细胞白血病中的干/祖细胞相关的微小RNA特征
Mol Biol Rep. 2019 Feb;46(1):1295-1306. doi: 10.1007/s11033-019-04600-5. Epub 2019 Feb 2.
5
MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.微小 RNA 表达特征与急性白血病的谱系和生存相关。
Blood Cells Mol Dis. 2010 Mar 15;44(3):191-7. doi: 10.1016/j.bcmd.2009.12.010. Epub 2010 Jan 27.
6
Six Candidate miRNAs Associated With Early Relapse in Pediatric B-Cell Acute Lymphoblastic Leukemia.六种与儿童 B 细胞急性淋巴细胞白血病早期复发相关的候选 miRNA。
Anticancer Res. 2020 Jun;40(6):3147-3153. doi: 10.21873/anticanres.14296.
7
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia.微小RNA表达特征可准确区分急性淋巴细胞白血病和急性髓细胞白血病。
Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19971-6. doi: 10.1073/pnas.0709313104. Epub 2007 Dec 4.
8
MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.miRNA 谱分析揭示骨化性纤维瘤中失调的 microRNAs 及其靶基因调控网络。
J Oral Pathol Med. 2018 Jan;47(1):78-85. doi: 10.1111/jop.12650. Epub 2017 Nov 1.
9
Exploring the Molecular Mechanisms of Pterygium by Constructing lncRNA-miRNA-mRNA Regulatory Network.构建 lncRNA-miRNA-mRNA 调控网络探究翼状胬肉的分子机制。
Invest Ophthalmol Vis Sci. 2020 Jul 1;61(8):12. doi: 10.1167/iovs.61.8.12.
10
Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia.儿童B细胞前体急性淋巴细胞白血病中的微小RNA差异表达
Pediatr Hematol Oncol. 2009 Jan;26(1):1-10. doi: 10.1080/08880010802378338.

引用本文的文献

1
Unraveling the Genetic Heterogeneity of Acute Lymphoblastic Leukemia Based on NGS Applications.基于二代测序技术应用解析急性淋巴细胞白血病的遗传异质性
Cancers (Basel). 2024 Nov 26;16(23):3965. doi: 10.3390/cancers16233965.
2
Regulation of immune cells by miR-451 and its potential as a biomarker in immune-related disorders: a mini review.miR-451 对免疫细胞的调控及其作为免疫相关性疾病生物标志物的潜力:小型综述。
Front Immunol. 2024 Jul 15;15:1421473. doi: 10.3389/fimmu.2024.1421473. eCollection 2024.
3
Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies.
个性化 CAR-T 疗法的进展:血液系统恶性肿瘤中生物标志物和治疗靶点的综合概述。
Int J Mol Sci. 2024 Jul 15;25(14):7743. doi: 10.3390/ijms25147743.
4
miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities.miR-142:血液系统恶性肿瘤的主调控因子及治疗机会。
Cells. 2023 Dec 30;13(1):84. doi: 10.3390/cells13010084.
5
MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia.miRNAs 在造血和急性淋巴细胞白血病中的作用。
Int J Mol Sci. 2023 Mar 12;24(6):5436. doi: 10.3390/ijms24065436.
6
MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools.微小RNA与儿童急性淋巴细胞白血病的诊断:系统评价、荟萃分析以及使用新型小RNA测序工具的重新分析
Cancers (Basel). 2022 Aug 17;14(16):3976. doi: 10.3390/cancers14163976.